Limin Chemical Co Ltd
Limin Group Co.,Ltd. engages in the research and development, production, and sale of fungicides, insecticides, herbicides, and biopesticides in China. The company offers various pesticides, including mancozeb, cymoxanil, fosetyl-aluminum, propineb, pyrimethanil, difenoconazole, m-phenylenediamine, chlorothalonil, thiacloprid, metiram, famoxadone, azoxystrobin, cyprodinil, folpet, captan, etc.; a… Read more
Limin Chemical Co Ltd (002734) - Total Liabilities
Latest total liabilities as of September 2025: CN¥3.06 Billion CNY
Based on the latest financial reports, Limin Chemical Co Ltd (002734) has total liabilities worth CN¥3.06 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Limin Chemical Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Limin Chemical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Limin Chemical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Limin Chemical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Jiangsu Changbao Steeltube Co Ltd
SHE:002478
|
China | CN¥3.04 Billion |
|
Zhejiang DunAn Artificial Environment Co Ltd
SHE:002011
|
China | CN¥5.45 Billion |
|
Natco Pharma Limited
NSE:NATCOPHARM
|
India | ₹17.76 Billion |
|
Longwell Co
TWO:6290
|
Taiwan | NT$3.20 Billion |
|
Hanwa Co., Ltd.
PINK:HNWAF
|
USA | $732.75 Billion |
|
YFY Inc
TW:1907
|
Taiwan | NT$80.46 Billion |
|
Arcadyan Technology Corp
TW:3596
|
Taiwan | NT$27.73 Billion |
|
Krungthai Card PCL
BK:KTC
|
Thailand | ฿63.35 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Limin Chemical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Limin Chemical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Limin Chemical Co Ltd (2008–2024)
The table below shows the annual total liabilities of Limin Chemical Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.96 Billion | -0.88% |
| 2023-12-31 | CN¥4.00 Billion | -5.12% |
| 2022-12-31 | CN¥4.22 Billion | +5.29% |
| 2021-12-31 | CN¥4.00 Billion | +49.77% |
| 2020-12-31 | CN¥2.67 Billion | +8.16% |
| 2019-12-31 | CN¥2.47 Billion | +187.94% |
| 2018-12-31 | CN¥858.48 Million | +30.86% |
| 2017-12-31 | CN¥656.05 Million | +34.37% |
| 2016-12-31 | CN¥488.24 Million | +29.16% |
| 2015-12-31 | CN¥378.01 Million | -10.61% |
| 2014-12-31 | CN¥422.87 Million | +27.63% |
| 2013-12-31 | CN¥331.33 Million | +11.74% |
| 2012-12-31 | CN¥296.52 Million | +17.07% |
| 2011-12-31 | CN¥253.28 Million | +30.86% |
| 2010-12-31 | CN¥193.55 Million | +15.00% |
| 2009-12-31 | CN¥168.30 Million | -29.63% |
| 2008-12-31 | CN¥239.16 Million | -- |